The Surprising Brain Connectivity Link Just Discovered Between Autism and ADHD

The diagnostic walls separating two of the most prevalent neurodevelopmental conditions in modern psychiatry have just fractured. In a landmark study published in Molecular Psychiatry, researchers from the Child Mind Institute discovered that the severity of autism traits—rather than a formal clinical label—dictates distinct patterns of brain connectivity and gene expression in children diagnosed with either autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD).

This discovery completely subverts decades of psychiatric orthodoxy. Historically, clinical frameworks have treated autism and ADHD as discrete categories with rigid, separate diagnostic criteria. If a child possessed symptoms of both, they were viewed as having two independent, co-occurring disorders. But the latest neuroimaging data reveals a far more complex biological reality: the autism and ADHD connection is not merely a behavioral overlap, but a deeply intertwined neurobiological continuum driven by shared gene expressions and overlapping brain network architecture.

Led by Dr. Adriana Di Martino, Founding Director of the Autism Center at the Child Mind Institute, researchers utilized resting-state functional MRI to analyze the brains of 166 verbal children between the ages of 6 and 12. The cohort included children diagnosed exclusively with autism, and children diagnosed exclusively with ADHD.

The results were unequivocal. Children who exhibited more pronounced autism symptoms demonstrated unusually strong connectivity between specific, large-scale brain networks—regardless of whether their official medical file said "Autism" or "ADHD". The biological signature did not respect the boundaries of the DSM-5. Instead, the intensity of the symptoms themselves shaped the wiring of the brain, proving that the underlying mechanisms governing these conditions operate on a dimensional scale rather than a categorical binary.

The Neurological Architecture of a Shared Biology

To understand the magnitude of this discovery, we have to look precisely at where this hyperconnectivity occurs. The resting-state functional MRI used in the Child Mind Institute study is uniquely designed to measure how different regions of the brain communicate when a person is not actively engaged in a specific task. This "rest" state provides a clear window into the brain's baseline organizational structure.

Researchers pinpointed the anomalies within two critical neural systems: the frontoparietal (FP) network and the default-mode (DM) network.

The default-mode network is a constellation of brain regions that ignite when the mind is at rest, engaged in internal thought, daydreaming, or processing complex social information and self-reflection. The frontoparietal network, conversely, is heavily implicated in executive functioning, sustained attention, and cognitive control—the exact areas where individuals with ADHD and autism frequently encounter friction.

In typical neurological development, the communication between the FP and DM networks gradually decreases over time. As a child ages, these brain regions undergo a process of specialization, segregating their functions so the brain can efficiently switch between internal reflection and external task execution.

In the children studied by Dr. Di Martino's team, this natural separation did not occur. Children displaying intense autism-like traits maintained a persistent "hyperconnectivity" between the frontoparietal and default-mode networks. The networks failed to segregate, remaining heavily entangled. Crucially, this hyperconnected brain signature appeared robustly in children who were formally diagnosed with ADHD but who exhibited qualitative autism symptoms, entirely bypassing the requirement for an official ASD diagnosis.

The researchers did not stop at imaging. By utilizing a highly advanced computational method known as in silico spatial transcriptomic analysis, the team mapped the specific connectivity patterns observed in the children's MRI scans against comprehensive databases of brain gene expression.

They found a direct alignment. The areas of the brain exhibiting this abnormal hyperconnectivity correspond precisely to regions where specific genes governing early neural development are expressed. Many of these identical genes have been previously flagged in separate genetic studies as high-risk markers for both autism and ADHD. This genetic overlap provides the ultimate biological receipt: the shared behavioral traits observed in clinical settings are actively driven by shared genetic instructions mapping the maturation of large-scale brain networks.

Divergent Maturation: The University of Minnesota Data

If the Child Mind Institute study proves that autism and ADHD share a genetic and network connectivity foundation, a massive secondary study published in early 2026 reveals exactly how those shared vulnerabilities manifest into different structural outcomes.

In January 2026, researchers from the University of Minnesota released the largest brain imaging study of its kind, analyzing structural data from 9,647 individuals aged 5 to 64. This immense dataset included 1,533 people with ADHD, 1,080 autistic individuals, and over 7,000 neurotypical controls across 67 different data acquisition sites.

While the Child Mind Institute focused on how brain networks communicate (functional connectivity), the University of Minnesota team measured how the physical structure of the brain matures—specifically focusing on cortical thickness (the depth of the grey matter) and cortical curvature (the intricate folds of the brain's surface).

The findings present a perfect structural complement to the functional connectivity data. The U of M researchers discovered that while autism and ADHD share early developmental vulnerabilities, their physical brain maturation ultimately follows radically opposite trajectories.

Autistic Neuroanatomy: Autistic participants exhibited a regionally thinner cortex and altered curvature patterns, particularly within the Cingulo-Opercular network—a system responsible for cognitive control, task switching, and regulating alertness.
ADHD Neuroanatomy: Conversely, participants with ADHD displayed a regionally thicker cortex, predominantly within the default-mode network (including the left ventromedial prefrontal cortex and right orbitofrontal cortex) and somatomotor networks.
Neurotypical Baselines: The control group demonstrated intermediate cortical thickness patterns, sitting directly between the thinning seen in autism and the thickening seen in ADHD.

Both conditions showed significant physical alterations in the exact same overarching system—the Fronto-Parietal Network, specifically regions like the left POS2 and left area 7Pm, which act as integrative hubs for diverse cognitive operations. In these shared regions, autistic brains possessed the thinnest cortex, ADHD brains the thickest, and neurotypical brains remained in the middle.

This proves that autism and ADHD represent diverging extremes of cortical maturation stemming from a shared biological vulnerability. The underlying genetics and network connectivity are deeply linked, but as the brain physically grows, the structural development pulls in opposite directions, resulting in the distinct yet overlapping behavioral profiles we see in patients today.

The Invisible Demographic: Who is Actually Affected?

To fully grasp the societal and clinical impact of these neurological discoveries, we must examine the lived reality of the patients who occupy the space between these two diagnoses. Within the neurodivergent community, this heavy overlap is often colloquially referred to as "AuDHD". While AuDHD is not a medically recognized classification in the DSM-5, the latest biological data suggests the community's self-identification has been ahead of the clinical science for years.

The statistics surrounding co-occurrence are staggering. Clinical studies estimate that up to 80 percent of children formally diagnosed with autism also meet the diagnostic criteria for ADHD. In the reverse direction, approximately 30 to 45 percent of individuals with ADHD display significant, measurable autistic traits.

Yet, the medical system is failing to capture this overlap accurately. A comprehensive 2025 analysis of 1.9 million U.S. health insurance claims revealed that only 1.7 percent of adults diagnosed with ADHD possessed a co-existing ASD diagnosis on their medical records. This massive discrepancy between the estimated prevalence of overlapping traits (up to 45 percent) and the actual medical coding (1.7 percent) points to a systemic failure in how modern psychiatry identifies and categorizes neurodevelopmental conditions.

Dr. Colleen Cira, a clinical psychologist who was diagnosed with ADHD at age 35 and autism seven years later, perfectly encapsulates the psychological friction of living with this unmapped biological overlap. Because the two conditions share a neurobiological root but express themselves in opposing structural extremes, the behavioral experience can be intensely contradictory. Individuals often report feeling constantly at war with their own neurology—craving the rigid, predictable routines demanded by their autism, while simultaneously battling the impulsive, under-stimulated novelty-seeking driven by their ADHD.

Because diagnostic frameworks force clinicians to look for one condition or the other, millions of children and adults have been misdiagnosed, partially diagnosed, or entirely overlooked. A child with severe ADHD who also exhibits qualitative social rigidity and sensory sensitivities might fail to meet the strict, multi-tiered threshold required for an official autism diagnosis. Under the old categorical model, those autism traits would be treated as behavioral anomalies or ignored entirely.

The new brain-gene signature data demands an end to this selective blindness. Dr. Di Martino notes exactly this phenomenon in her clinical observations: "We see in the clinic that some children with ADHD share symptoms qualitatively similar to those observed in autism, even if they do not fully meet the diagnostic criteria for ASD. By focusing on shared brain–gene expression patterns... we can point towards a shared biological basis of these clinical observations".

The immediate consequence of this data is validation for the millions of individuals who experience heavy impairments from dual traits. The 2025 health insurance data confirmed that patients exhibiting both ADHD and autism traits face significantly higher healthcare utilization, vastly increased costs, and much higher odds of facing additional compounding physical and mental health challenges. When people carry the biological burden of both extremes of cortical maturation, the impairment stretches across occupational, academic, and relational domains.

Rewriting the Diagnostic Rulebook: What Changes Now?

The immediate fallout from mapping the autism and ADHD connection is a forced migration away from categorical psychiatry toward dimensional psychiatry.

For the past fifty years, the Diagnostic and Statistical Manual of Mental Disorders (DSM) has operated on a categorical, box-checking methodology. If a patient exhibits five out of nine symptoms on a specific list, they receive a label. If they exhibit four, they do not. This binary system is excellent for administrative billing and insurance claims, but as the Child Mind Institute and University of Minnesota studies prove, it completely fails to reflect the fluid, dimensional nature of human neurobiology.

The new biological reality mandates that clinicians begin evaluating neurodevelopmental conditions on a spectrum of trait severity. Rather than asking, "Does this child have ADHD or Autism?" the diagnostic process must evolve to ask, "To what degree is this child's frontoparietal and default-mode network hyperconnected, and what specific interventions are required to address their unique symptom severity?"

This changes the entire architecture of psychiatric assessment. The Child Mind Institute is already championing this dimensional, transdiagnostic approach through its Healthy Brain Network, a landmark open-science initiative. By providing no-cost diagnostic assessments to thousands of children, the initiative is amassing the exact phenotypic and neuroimaging data required to build the next generation of psychiatric models—models rooted in biological reality rather than subjective behavioral checklists.

Short-Term Consequences: Colliding Therapies and Educational Systems

The immediate shockwaves of this discovery will hit clinical treatment plans and educational accommodations. For decades, the standard protocol for treating ADHD has involved central nervous system stimulants (such as methylphenidate or amphetamines) to increase dopamine and norepinephrine levels, effectively boosting the executive function of the frontoparietal network.

However, when a patient exists on the AuDHD spectrum—possessing the hyperconnected brain networks tied to high autism severity—traditional ADHD treatments can misfire drastically. Stimulant medications can inadvertently heighten the sensory processing sensitivities and rigidities associated with the individual's underlying autistic traits, leading to severe anxiety, emotional dysregulation, or intense overstimulation. Without understanding the shared brain-gene signature, psychiatrists have frequently prescribed medications that solve the executive dysfunction while accidentally amplifying the autism symptoms.

Therapists and prescribing physicians must now adapt their approaches to reflect how these two conditions biologically interact. Treatment protocols will have to shift from a localized focus (fixing attention) to a holistic focus (balancing the hyperconnected neural networks). Behavioral therapies, such as Cognitive Behavioral Therapy (CBT) or neurodiversity-affirming occupational therapy, must be blended to account for the dual vulnerabilities of the individual.

In the educational sector, the impact will be highly disruptive. Currently, public school systems design Individualized Education Programs (IEPs) and 504 plans based entirely on distinct medical or educational labels. A student with an ADHD label receives one set of accommodations (extra time on tests, preferential seating), while a student with an Autism label receives another (sensory breaks, social skills intervention).

Because the data now definitively proves that symptom severity—not the label—determines the brain's physical and functional deficits, schools will face immense pressure from pediatricians and parents to discard siloed accommodation models. A student with an official ADHD diagnosis who exhibits severe autistic traits mathematically possesses the same hyperconnected default-mode network as an officially diagnosed autistic child. Denying that student sensory accommodations based on a technicality of DSM-5 labeling is no longer medically defensible.

Long-Term Consequences: Precision Psychiatry and Early Biomarkers

Looking further down the timeline, decoding the autism and ADHD connection paves the way for a radical new era of precision medicine.

The integration of state-of-the-art neuroimaging with spatial transcriptomic analysis provides a precise blueprint of the genes responsible for large-scale brain network maturation. Because researchers now know exactly which gene expressions correspond to the failure of the FP and DM networks to separate, pharmaceutical companies and neuro-researchers have distinct, highly localized biological targets.

This lays the groundwork for identifying predictive biological biomarkers long before behavioral symptoms manifest. Currently, autism and ADHD are diagnosed retrospectively; a clinician observes a child struggling to socialize, read, or regulate their emotions at age five or six, and applies a label based on the resulting behavioral fallout.

By isolating the shared genetic signals and cortical developmental paths, pediatric medicine could theoretically screen for these specific network vulnerabilities in infancy. If a biomarker indicates that a child's frontoparietal and default-mode networks possess the genetic markers for hyperconnectivity, early intervention therapies could be deployed during the brain's most plastic developmental windows, potentially mitigating the most severe, life-limiting aspects of the symptoms without attempting to "cure" the underlying neurodivergence.

Furthermore, the discovery fundamentally alters how scientific clinical trials will be conducted. Historically, research studying a new therapeutic intervention for autism would strictly exclude participants who also had ADHD, in an attempt to keep the data "pure." We now know this methodology is inherently flawed. By excluding the overlap, decades of research have effectively ignored the massive percentage of the neurodivergent population that represents the biological norm of these intertwined conditions. Future clinical trials must embrace the transdiagnostic model, selecting participants based on specific neural profiles and symptom severity rather than arbitrary categorical labels.

The Next Scientific Frontier: Unresolved Questions

While the discovery of this shared brain-gene signature fundamentally rewrites our understanding of neurodevelopment, it also unearths a host of new, highly complex scientific questions that will drive the next decade of neurological research.

First, the demographic limitations of the initial neuroimaging studies must be addressed. The groundbreaking Child Mind Institute study explicitly utilized a cohort of 166 verbal children. Autism, however, is a vast spectrum that includes a significant percentage of non-speaking individuals, many of whom possess profound intellectual disabilities and vastly different support needs. It remains entirely unknown whether the hyperconnectivity between the frontoparietal and default-mode networks persists in non-verbal autistic populations, or if their symptom severity is driven by an entirely different cascade of neurological misfires.

Second, the question of adult neuroplasticity remains unresolved. The University of Minnesota study proved that cortical maturation diverges sharply across the lifespan of autistic and ADHD individuals, but the functional connectivity data currently focuses heavily on childhood developmental windows. How does this hyperconnectivity evolve as an AuDHD individual moves into their thirties, forties, or fifties? Does the aging brain naturally attempt to prune these hyperconnected networks, or do compensatory mechanisms develop in entirely different brain regions to manage the overlapping symptoms?

Finally, researchers must dissect the "complex interplay" of phenotypic masking, particularly in female populations. Historically, both autism and ADHD have been chronically underdiagnosed in girls and women due to differences in socialization and the ability to internally mask neurodivergent traits. If symptom severity dictates the biological footprint in the brain, neuroimaging studies will need to determine if the intense psychological effort required to "mask" these traits physically alters the frontoparietal network's functional connectivity.

The biological borders that have governed developmental psychiatry for a half-century have permanently fallen. The realization that autism and ADHD share the exact same genetic instructions and brain connectivity patterns—only to violently diverge in their physical cortical maturation—proves that human neurobiology is infinitely more connected than our medical textbooks have allowed. As researchers continue mapping the deep integration of our neural networks, the future of psychiatric care relies entirely on abandoning the boxes we check, and treating the highly complex, dimensional brain in front of us.